Alternatives to ConcertAI

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Charm Evolution serves as a comprehensive oncology information management system that centralizes all processes related to chemotherapy prescribing and administration, thereby improving safety, consistency, and accountability by substituting handwritten orders with digital prescriptions that are meticulously monitored through order adjustments and orphan management for precise wastage reporting. It consolidates accurate and secure patient records and treatment data from various sources into a unified database, facilitating informed and efficient decision-making directly at the point of care. Furthermore, an intelligent pathway engine automates treatment protocols, enhances scheduling in accordance with regimens, and caters to both adult and pediatric oncology and hematology through customizable treatment libraries, protocol validation, and management of clinical trials. Additionally, integrated pharmacy management offers bi-directional connectivity with compounders, along with the option to customize worksheets and labels, while the scheduling component maximizes resource allocation and minimizes the need for patient travel, ultimately contributing to a more effective healthcare delivery system. This holistic approach fosters an environment where healthcare providers can deliver optimal care to their patients.

Flatiron Health's Evidence Solutions provide a versatile method for generating real-world evidence, both prospective and retrospective, which aids life sciences companies in efficiently meeting their oncology research objectives. At the heart of these offerings is Flatiron Horizon, a comprehensive platform that combines a rich database of more than 5 million anonymized patient records and 1.5 billion data points, coupled with advanced curation techniques and disease-specific machine learning models. This innovative platform is designed to facilitate various phases of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Furthermore, Flatiron's services deliver customized real-world data configurations that cater specifically to oncology, enabling prospective evidence generation through minimally invasive studies and optimizing protocols for better patient identification. Additionally, the platform ensures a streamlined transfer of data from electronic health records to electronic data capture systems with the functionality of Flatiron Clinical Pipe, enhancing overall research efficiency and effectiveness. Such capabilities position Flatiron Health as a leader in transforming oncology research through the power of real-world data.

Genoox is revolutionizing the field of genomics through its dynamic and expanding community, which enables the accumulation of the most pertinent database and facilitates the delivery of actionable, real-world genomic insights that significantly affect lives, enhance clinical outcomes, and influence healthcare business practices. By harnessing community power, Genoox merges public data with community-generated information to optimize the journey from DNA sample to clinical report, thereby improving patient care through the accessibility and applicability of genomic data at critical moments. The company's innovative solutions are transforming the landscape of genomics, while also supporting research and life sciences enterprises with an insightful platform that leverages real-world data and evidence, bolstered by comprehensive genomic analytics, which assists researchers in simplifying intricate genomic information and achieving meaningful breakthroughs with cutting-edge genetic tools. Moreover, Genoox collaborates with biosystems firms like DNA sequencing companies to integrate its advanced genomic engine with specialized assays, further enhancing the capabilities of the entire genomics ecosystem. Ultimately, Genoox stands at the forefront of genomic innovation, consistently aiming to empower healthcare professionals and researchers alike.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

Efficiently merge the multiomic information of patients with their health records to provide more tailored care solutions. Implement specialized data repositories to facilitate extensive analyses and foster collaborative research initiatives on a population-wide scale. Expedite research processes by leveraging adaptable workflows and comprehensive computational tools. Ensure the safeguarding of patient privacy through adherence to HIPAA standards, complete with robust data access and logging mechanisms. AWS HealthOmics empowers healthcare and life science organizations, along with their software collaborators, to securely store, retrieve, and analyze diverse omics data, such as genomic and transcriptomic information, ultimately yielding valuable insights that enhance health outcomes and propel scientific advancements. Manage and evaluate omics data for extensive patient cohorts to discern how variations in omics relate to phenotypic expressions within the population. Develop consistent and accountable clinical multiomics workflows designed to minimize turnaround times while boosting efficiency. Seamlessly incorporate multiomic assessments into clinical trials aimed at evaluating new therapeutic candidates, thereby enhancing the overall drug development process. By harnessing these innovative approaches, organizations can ensure a deeper understanding of patient health and contribute to groundbreaking research findings.

Sofpromed specializes in providing electronic data capture (EDC) solutions tailored for companies in the biotechnology, pharmaceutical, and medical device sectors involved in clinical trials ranging from phases I to IV. An EDC system serves as a software platform that facilitates the collection, validation, and exportation of data gathered during clinical studies. The EDC software developed by Sofpromed is utilized in clinical trials globally, spanning a diverse range of therapeutic fields such as oncology, hematology, cardiovascular health, metabolic disorders, central nervous system (CNS) issues, dermatology, infectious diseases, respiratory conditions, and pain management, among others. It boasts a user-friendly design that is simple and intuitive, allowing for rapid data entry and easy navigation. The platform also incorporates robust features such as access control and data encryption to ensure data security. Being fully web-based, it eliminates the need for any installations, providing convenience and efficiency. Additionally, it offers daily data backups and uninterrupted service, making it reliable for users. The system is compatible across various devices, browsers, and operating systems, enhancing its accessibility. It includes integrated monitoring, data management, and reporting functionalities, ensuring compliance with HIPAA, GCP, and 21 CFR standards. Furthermore, Sofpromed offers a convenient billing structure with a monthly flat rate, making it a practical choice for clinical trial needs. Overall, its comprehensive features and user-centric design make it an essential tool for conducting efficient and compliant clinical trials.

Amazon Comprehend Medical is a natural language processing (NLP) service compliant with HIPAA that leverages machine learning to retrieve health information from medical texts without requiring any prior machine learning expertise. A significant portion of health data exists in unstructured formats such as physician notes, clinical trial documentation, and patient medical records. The traditional approach of manually extracting this data is labor-intensive and inefficient, while automated methods based on strict rules often overlook crucial contextual details, leading to incomplete data capture. Consequently, this limitation results in valuable information remaining untapped for large-scale analytical efforts that are essential for progressing the healthcare and life sciences sectors, ultimately impacting patient care and operational efficiencies. By addressing these challenges, Amazon Comprehend Medical enables healthcare professionals to harness their data more effectively for better decision-making and innovation.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

Microsoft Cloud for Healthcare serves as an all-encompassing platform aimed at revolutionizing the healthcare sector by utilizing AI-driven solutions, integrating data, and ensuring secure, interconnected experiences. This platform assists healthcare providers, payors, and life sciences entities in enhancing patient care, optimizing operations, and bolstering research efforts. It provides resources for protecting confidential information, streamlining clinical processes, and fostering better patient engagement. By harnessing actionable insights derived from integrated clinical and operational data, Microsoft Cloud for Healthcare empowers organizations in the healthcare field to achieve favorable results, boost efficiency, and lower expenses. Ultimately, this innovative platform is pivotal in shaping the future of healthcare delivery.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

TriNetX operates as a worldwide health research network that links healthcare institutions with life sciences firms to enhance real-world research and expedite the creation of innovative therapies. Utilizing a self-service platform that adheres to HIPAA, GDPR, and LGPD regulations, TriNetX allows users to tap into federated electronic health records, various datasets, and consulting collaborations. This capability empowers the global research community to enhance protocol design, optimize trial operations, improve safety signal assessments, and amplify the generation of real-world evidence. The network boasts a comprehensive dataset representing over 275 million patients from 150 healthcare organizations across 25 nations, thereby offering a rich resource for research endeavors. Researchers have taken advantage of the TriNetX network to examine upwards of 26,000 protocols and present more than 7,000 clinical trial opportunities to the healthcare members, thereby cutting site identification time for clinical trials by an impressive 50%. In doing so, TriNetX not only fosters collaboration among entities but also catalyzes advancements in medical research and patient care worldwide.

Inspirata is a specialized oncology data and analytics platform built to help cancer programs improve care delivery and operational performance. It leverages AI-driven technology to automate cancer casefinding, data extraction, and reporting with high accuracy. The platform supports compliance with regulatory requirements while significantly reducing manual registry work. Inspirata transforms unstructured clinical data into actionable insights that fuel research and clinical decision-making. Real-time data access helps improve trial accrual and ensures equitable patient access to clinical studies. Patient navigation tools support coordinated care from screening to survivorship. By improving efficiency, Inspirata allows staff to focus on higher-value patient and research activities. The platform integrates seamlessly with major EHR and clinical systems. Trusted by hundreds of hospitals, Inspirata delivers measurable improvements in oncology operations. It helps cancer centers maximize impact while minimizing cost and complexity.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Deeplink Medical has centered its offerings around the MIRIO platform, which is designed to cater to the varying use cases and requirements of stakeholders engaged in medical imaging within oncology, both in clinical settings and routine practice. Our services encompass three distinct yet interconnected solutions: MIRIO, which tracks evaluations of solid tumors and monitors the therapeutic responses of oncology patients; a streamlined patient pathway that bridges hospital facilities with private medical practices; and an Imaging CRO dedicated to the oversight of imaging data in oncological clinical trials. The development of our innovative solutions is bolstered by a scientific board, ensuring a robust foundation for our offerings. Additionally, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, facilitating real-time data structuration in accordance with RECIST 1.1 and iRECIST guidelines right from the moment the data is generated at investigation sites. This enables immediate evaluation of treatment responses based on established international standards, ultimately enhancing the quality and efficiency of patient care in oncology. By integrating these services, we aim to provide a comprehensive approach that supports healthcare professionals in delivering optimal treatment outcomes.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

NVIDIA® Parabricks® stands out as the sole suite of genomic analysis applications that harnesses GPU acceleration to provide rapid and precise genome and exome analysis for various stakeholders, including sequencing centers, clinical teams, genomics researchers, and developers of high-throughput sequencing instruments. This innovative platform offers GPU-optimized versions of commonly utilized tools by computational biologists and bioinformaticians, leading to notably improved runtimes, enhanced workflow scalability, and reduced computing expenses. Spanning from FastQ files to Variant Call Format (VCF), NVIDIA Parabricks significantly boosts performance across diverse hardware setups featuring NVIDIA A100 Tensor Core GPUs. Researchers in genomics can benefit from accelerated processing throughout their entire analysis workflows, which includes stages such as alignment, sorting, and variant calling. With the deployment of additional GPUs, users can observe nearly linear scaling in computational speed when compared to traditional CPU-only systems, achieving acceleration rates of up to 107X. This remarkable efficiency makes NVIDIA Parabricks an essential tool for anyone involved in genomic analysis.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Verana Health operates as a platform for real-world data that converts both structured and unstructured information from electronic health records into curated, de-identified, disease-focused data modules through its clinician-informed and AI-enhanced VeraQ population health data engine. By aggregating data from key collaborations with prominent medical registries, including the American Academies of Ophthalmology, Neurology, and Urological Association, the platform integrates insights from over 20,000 clinicians and approximately 90 million patient records, thereby supplying high-quality datasets in near real-time for the purposes of generating real-world evidence, identifying clinical trial sites and subjects, reporting clinician quality, and managing medical registries. Users can access this wealth of information through cloud services like AWS Data Exchange and Amazon Redshift, which provide self-service API access, a user-friendly dashboard, and tools for customizable cohort discovery. Furthermore, the system employs advanced AI and machine learning algorithms along with comprehensive data quality assessments to ensure the reliability and accuracy of the information provided. This innovative approach not only facilitates efficient data utilization but also enhances the overall quality of healthcare research and practice.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

OM1 leverages artificial intelligence and extensive clinical data to significantly enhance research productivity and clinical decision-making via high-performance predictive models. The OM1 Patient Finder employs advanced AI technology seamlessly integrated with the OM1 Real-World Data Cloud. By merging various aspects of patient journeys from diverse data sources, it effectively identifies individuals most likely to be affected by the target condition. We have developed an intelligent data cloud that allows various healthcare stakeholders to access, analyze, and utilize outcomes data in a manner that is not only more comprehensive but also clinically relevant and precise. This enables rapid, accurate, and cost-effective access to research-grade insights regarding effectiveness, value, and safety. Moreover, it allows for the quantification of outcomes, facilitating the demonstration of value in risk-sharing and outcomes-based payment models. As a result, healthcare providers can make informed decisions grounded in real-world evidence.

BEKhealth provides an innovative clinical research platform, known as the BEKplatform, which leverages artificial intelligence to streamline the extraction, interpretation, and standardization of both structured and unstructured electronic medical record data, encompassing various elements such as lab results, diagnoses, physician notes, pathology reports, and PDFs. This integrated system creates a searchable, longitudinal patient graph designed to assist life sciences and healthcare organizations in swiftly pinpointing protocol-eligible patients while enhancing trial feasibility, site selection, and recruitment processes. By utilizing advanced deep learning techniques and natural language processing, BEKhealth transforms chaotic clinical data into precise, actionable insights, allowing for the generation of sophisticated queries and patient cohorts. This method not only identifies more qualified candidates compared to traditional manual chart reviews but also provides real-time reports and dashboards that facilitate informed decision-making across research networks, ultimately improving the efficiency and effectiveness of clinical trials. The ability to generate these insights in real-time is a game-changer for organizations striving to maximize their research potential.

The Veradigm Real-World Evidence (RWE) analytics platform is an economical software-as-a-service solution designed for the clear and efficient analysis of real-world data. This platform is utilized by organizations in life sciences and clinical research to delve into electronic health records (EHR) data comprehensively. Adhering to OMOP standards, the analytical platform enhances the efficiency and reliability of generating real-world evidence. By leveraging the Veradigm Network data, users can execute population analyses in mere minutes, build reusable patient cohorts with consistent terminology across various data sources, and facilitate repeatable retrospective studies. Additionally, the platform supports analysis on any dataset that fits within the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), including those sourced from Veradigm Network EHR Data. Overall, this powerful tool is designed to streamline research processes and enhance the quality of insights derived from real-world data.

Mediktor stands out as the most precise AI medical assistant designed for triage and prediagnosis purposes. We conduct real-world clinical trials involving actual patients, ensuring that our AI solution is validated through clinical evidence. Our understanding of your business allows us to tailor our solution to deliver optimal value, aligning seamlessly with your objectives. Over the past decade, we have collaborated with leading health organizations globally. Our award-winning clinical trials yield significant and convincing clinical evidence that sets a new benchmark in the industry. These trials are carried out in real-world settings and are directed by independent researchers who formulate the protocols, collect data, and synthesize the results. Furthermore, our findings are regularly published in top-tier scientific journals, contributing to the broader medical community. Our AI-driven system emulates the questioning style of a physician, ensuring a comprehensive assessment of patient needs. This unique approach not only enhances accuracy but also fosters trust and reliability in digital health solutions.

CluePoints offers a cloud-based platform that utilizes AI for risk-based quality management and oversight of clinical data, employing sophisticated techniques like machine learning and deep learning to enhance the reliability, precision, and safety of data and processes in clinical trials. This platform stands out with its capability for real-time anomaly detection and centralized statistical monitoring, effectively spotting outliers and data risks that conventional methods may overlook, thereby empowering teams to proactively address risks and expedite the resolution of issues while adhering to FDA, EMA, and ICH standards. Additionally, CluePoints features tailored solutions including Risk-Based Quality Management (RBQM) for timely risk identification, Medical & Safety Review (MSR) for efficient review and query management, Intelligent Medical Coding for automated clinical coding suggestions, and Intelligent Query Detection (IQD) to facilitate the detection of discrepancies, along with tools like the Site Profile & Oversight Tool (SPOT) designed for dynamic site monitoring to ensure optimal oversight throughout the trial process. These advanced features collectively contribute to improving the overall efficiency and effectiveness of clinical trials.

To shape the future effectively, one must take proactive steps in creating it. Exigyn offers immediate access to a financial analyst right at your fingertips. You can easily design clinical trial scenarios, evaluate cash flow sustainability, and still enjoy your evening meal. By utilizing essential KPIs such as patient enrollment, site efficiency, and cost per patient, you can enhance trial expenditures. Implement our comprehensive multidimensional database for accurate and thorough tracking, down to the level of individual vendor names. With just a single click, you can swiftly adjust financial predictions, budgets, departmental structures, project listings, charts of accounts, and expenditures. Simplify personnel planning by aligning staff numbers with clinical objectives and optimizing your organizational layout. Equipped with user-friendly tools for monitoring roles, salary ranges, and anticipated hires, you can confidently prepare for what lies ahead. Moreover, our solution incorporates real-time data, automating clinical accrual processes, which allows you to conserve valuable time and resources while focusing on what matters most. Embrace the future of financial management and make informed decisions today.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

IVR Clinical Concepts is a company that focuses on offering technology for virtual clinical trials and solutions for patient engagement. Their products feature electronic patient-reported outcomes and patient diaries, which are designed to enhance data quality by minimizing errors, thereby shortening timelines and reducing overall costs. Furthermore, they provide comprehensive patient recruitment and outreach services that emphasize outreach, pre-screening, and the collection of real-time data. The solutions for subject screening, registration, and randomization are characterized as modular, tailored, adaptable, and customizable. In addition to these services, IVRCC also delivers clinical trial material management solutions aimed at lightening the workload while ensuring greater control, along with eClinical integration services that work to unify data seamlessly. Their chart review services offer insights based on real-world data and clinical experiences. By prioritizing custom, modular, and adaptable solutions, IVRCC strives to enhance the patient experience and maximize the success rates of clinical trials. This commitment to innovation positions IVRCC as a leader in the industry, dedicated to improving the efficacy of clinical research.

Atropos Health delivers immediate access to evidence derived from real-world data, effectively bridging the gaps in the healthcare and life sciences sectors. This innovative approach has been shown to enhance clinical outcomes, speed up research initiatives, and improve operational efficiency. By swiftly converting medical data into actionable real-world evidence, Atropos Health reduces the time needed for research from months to mere minutes. Central to its offerings is a generative evidence acceleration operating system that can securely incorporate and structure medical data for future applications. With robust analytics tools, users can generate evidence on demand, utilizing either their own data following a quick setup or tapping into our extensive global evidence network, which includes over 160 million patient records and a library of 10,000 prior studies. Partnering with Atropos Health allows leading health systems and life science organizations to fast-track research, refine clinical trials, enhance clinical decision-making, manage care variation effectively, and much more. Together, we are reshaping the future of healthcare through data-driven insights and collaborative innovation.

Marvin is a software platform that provides solutions for Clinical Data Management. This includes EDC (including IWRS/Drug Management and WebPRO), reporting, and more. ), Coding and Composer (CDISC ODM based study design including SDTM map), SDTM visualization, Clinical Document Management, (eTMF), and a mobile app for direct communication between Investigators & patients. Our software and technical support help accelerate clinical trials around the world. Founded in 2002, XClinical is an international eClinical vendor. Marvin, the company's software platform, provides solutions for Clinical Data Management such as EDC (including IWRS/Drug Management and WebPRO), reporting, and more. ), Coding and Composer (CDISC ODM based study design including SDTM map), SDTM visualization, Clinical Document Management, (eTMF), and a mobile app for direct communication between Investigators & patients. Our software and technical support help accelerate clinical trials around the world.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

Truveta operates as a health data and analytics platform focused on leveraging information to enhance patient lives. By consolidating de-identified electronic health records from more than 30 healthcare systems, it provides researchers with access to a rich array of patient data, which includes clinical notes, imaging, and genomic information. This vast repository represents data from upwards of 120 million patients, giving a well-rounded perspective on healthcare delivery throughout the United States. The Truveta Studio, which serves as the platform's analytics hub, equips researchers with sophisticated tools like notebooks and dashboards, all maintained within a secure and HIPAA-compliant framework. With daily updates to its data, the platform guarantees that insights into patient care and outcomes are both current and relevant. Furthermore, Truveta's dedication to data integrity is showcased by its implementation of the Truveta Language Model, an advanced AI framework that efficiently translates EHR data into precise and reliable data points for the advancement of medical research. This commitment not only enhances research capabilities but also fosters a deeper understanding of healthcare trends and patient needs, ultimately contributing to improved health outcomes.

SciSpace BioMed serves as an innovative AI-powered "co-scientist" tailored for the field of biomedical research, integrating an extensive literature repository with over 150 bio-tools and more than 100 academic databases and software applications to enhance intricate research processes, which encompass areas such as genomics, single-cell analysis, drug discovery, and clinical genomics. This platform empowers researchers to pose questions in natural language, manage datasets, analyze variants or multi-omics results, plan experimental workflows, reason about clinical biology and diseases, and produce publication-ready materials, including figures, tables, and presentations, all while ensuring transparency and proper citations. Furthermore, users have the capability to engage with scientific articles through a “chat with PDF” feature that allows them to highlight and seek clarification on challenging text, mathematical content, or tables, making it an excellent tool for grasping complex methods or concepts. For the purposes of literature review or preliminary research, its AI-enhanced semantic search can sift through millions of academic papers, providing citation-supported summaries that facilitate deeper understanding and exploration of the relevant literature. This functionality significantly accelerates the research process, allowing scientists to focus more on their discoveries rather than administrative tasks.

GPT-Rosalind is an advanced reasoning model created by OpenAI, aimed at enhancing scientific exploration in fields like biology, drug development, and translational medicine. Tailored for workflows in life sciences, it assists researchers in managing extensive literature, experimental findings, and specialized databases to formulate and test innovative concepts. By integrating a profound understanding of disciplines such as chemistry, genomics, protein engineering, and disease biology with sophisticated tool-usage capabilities, it effectively interacts with scientific databases, examines experimental results, and facilitates intricate, multi-stage reasoning tasks. Its functionalities span evidence synthesis, hypothesis formulation, literature assessment, sequence analysis, and experimental design, empowering scientists to transition more swiftly from raw data to meaningful insights. Furthermore, GPT-Rosalind revolutionizes cumbersome, time-consuming research methodologies into streamlined, AI-enhanced workflows, ultimately fostering a more productive scientific environment. This model exemplifies the fusion of artificial intelligence with scientific inquiry, paving the way for groundbreaking discoveries.

The advanced features of the Inovalon ONE® Platform enable our clients and collaborators to thrive by utilizing extensive industry connections, vast primary-source real-world data, advanced analytics, and robust cloud-based technologies to enhance healthcare outcomes and economics. Central to modern healthcare is the necessity to consolidate and scrutinize vast amounts of varied data, extract valuable insights from these analyses, and apply this knowledge to effect significant improvements in patient outcomes, operational performance, and healthcare economics. With analytics and capabilities employed by over 20,000 clients, we draw upon the primary source data from more than 69.5 billion medical events, encompassing one million healthcare professionals, 611,000 clinical environments, and 350 million distinct patients. This extensive network of data and analytics is crucial for driving innovation and efficiency in the healthcare sector, fostering an environment where informed decisions lead to substantial advancements.

Loftware Cloud Clinical Trials is a robust solution tailored to meet the stringent compliance needs of clinical trials. It enables organizations to efficiently manage the creation, approval, and distribution of clinical trial labels and booklets. With an intuitive interface, Loftware ensures adherence to regulatory standards, such as FDA and EMA, by providing templates, barcode functionality, and real-time updates. The platform's seamless integration with existing systems enhances productivity and reduces the risks associated with manual labeling processes, making it ideal for global clinical trial operations.

Partek bioinformatics software offers robust statistical and visualization capabilities through a user-friendly interface that caters to researchers of varying expertise. This innovation allows users to navigate genomic data with unprecedented speed and ease, truly embodying our motto, "We turn data into discovery®." With pre-installed workflows and pipelines in a simple point-and-click format, even complex NGS and array analyses become accessible to all scientists. Our combination of custom and public statistical algorithms works seamlessly to transform NGS data into valuable biological insights. Engaging visual tools like genome browsers, Venn diagrams, and heat maps illuminate the intricacies of next-generation sequencing and array data with vibrant clarity. Additionally, our team of Ph.D. scientists is always available to provide support for NGS analyses whenever queries arise. Tailored to meet the demanding computational requirements of next-generation sequencing, the software also offers flexible options for installation and user management, ensuring a comprehensive solution for research needs. As a result, users can focus more on their research and less on technical challenges.

PicnicHealth serves as a bridge between patients and researchers, providing comprehensive and purpose-driven real-world data. By engaging with patients who willingly share their medical information for research purposes, we can create an extensive understanding of patient health that encompasses all their healthcare providers, rather than being limited to a single site or specialist. Our established patient communities and efficient recruitment methods through various direct-to-patient channels make it simple to assemble the right cohort of patients. In just ten minutes, patients can register and give consent, gaining access to their own medical records. If you currently have patients involved in ongoing registries or clinical trials, consider directing them to PicnicHealth for streamlined setup. Our research platform is designed to offer tailored real-world data at the individual patient level, allowing for precise specifications regarding the data elements to be extracted from medical records, such as doctors' notes and narrative text. This innovative, patient-focused approach not only enhances the data we gather but also encourages patients to play an active role in the research process. Ultimately, we believe that empowering patients in this way fosters a deeper understanding of health outcomes and improves the overall quality of research.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.